Mayne Pharma Group
Mayne Pharma Group Limited is a specialty pharmaceutical company listed on the ASX, focused on commercializing pharmaceuticals and improving patient access to life-enhancing medications. The company has a 40-year track record of innovation in developing oral drug delivery systems, offering a portfolio of branded and generic drugs in therapeutic areas like women's health and dermatology.
Short position
Mayne Pharma Group (ASX:MYX) has 2.23% of its shares on issue reported as short positions as of 5 Oct 2026, or about 1,825,643 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has fallen 0.32 percentage points. Its highest recorded short interest was 13.53% in May 2017. MYX is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Mayne Pharma Group (MYX) company profile
Profile, insiders and operations
Company
AI-generated research profile of Mayne Pharma Group
MYX intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links